VX-950 and Peginterferon for Hepatitis C

NCT00251199 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: VX-950
DRUG: peginterferon

Sponsor

Vertex Pharmaceuticals Incorporated